Products

eMurmur Heart AI
eMurmur
Cardiology AI
eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings.
eMurmur ID
eMurmur
Cardiology AI
AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers.

See all 2 products →

About eMurmur

eMurmur, operating under CSD Labs International Inc. in Canada and CSD Labs GmbH in Austria, is a digital health company specializing in machine learning for the analysis of digital auscultation data. The company provides an AI-enabled digital auscultation platform that allows clinicians to listen to, record, stream, and analyze heart and lung sounds. Their product positioning focuses on quantitative, documented stethoscope interpretation for various clinical workflows, including screening, monitoring, diagnosis, consultation, telehealth, and home health. The platform is designed to be stethoscope-agnostic, working across supported digital stethoscope models and integrating with third-party software.

eMurmur’s Heart AI detects abnormal heart murmurs, distinguishes recordings without abnormal murmurs, identifies S1 and S2 heart sounds, and calculates loudness metrics for heart-sound components. The company also offers Lung AI capabilities, including the detection of crackles and other abnormal lung sounds, as well as remote and asynchronous listening workflows. Their technology is clinically validated, FDA cleared, CE marked, and ISO 13485:2016 certified. In January 2026, eMurmur received FDA clearance for its open murmur-detection AI, which can be used with various supported digital stethoscopes and integrated into third-party software. Additionally, eMurmur provides educational auscultation products, such as the Littmann Learning App, and offers a web-based platform for cardiac sound analysis and collaboration, which emphasizes recording, comparison of auscultation sounds over time, and AI-assisted murmur detection.

Focus Areas

digital auscultation AI-powered heart murmur detection AI-powered lung sound analysis telehealth medical education cardiovascular health pulmonary health

Business Intelligence

Technologycloud-based, machine learning-based, end-to-end encrypted web portal and mobile app, hardware-agnostic AI layer

What Physicians Need to Know

Digital Auscultation Platform
eMurmur offers a web-based platform and mobile app for streaming, capturing, storing, and analyzing digital auscultation sounds (heart, lung, and bowel). It supports both live, real-time remote listening and asynchronous recording for later review.
AI-Powered Heart Murmur Detection
The company is a leader in automated heart murmur detection technology, which is FDA cleared and CE marked. Their AI analyzes recordings in seconds to detect the presence or absence of abnormal heart murmurs, providing objective insights and a 'Heart AI Score' for recording reliability.
AI-Powered Lung Sound Analysis
eMurmur also provides AI for lung sound analysis, including the detection of crackles and wheezes.
Telehealth & Remote Care
The platform is designed for telehealth and remote consultations, enabling healthcare professionals to screen, monitor, diagnose, and consult on heart, lung, and bowel health remotely. It facilitates live streaming of auscultation sounds to consulting specialists and asynchronous review of recorded exams.
Medical Education
eMurmur offers innovative educational solutions for auscultation teaching and training, including the Littmann® Learning App, which provides access to real patient heart and lung sounds and guided learning modules.
Hardware Agnostic
A key differentiator is its ability to support multiple types of digital stethoscope hardware rather than requiring a single proprietary device. This includes compatibility with devices like Littmann 3200, ri-sonic, Thinklabs One, and Smartho-D2.
Regulatory Clearances
eMurmur's AI for heart murmur detection is FDA cleared (Class II) and CE marked (Class IIa), and their lung AI also holds MDR Class IIa clearance.
Physician Tip

eMurmur can significantly enhance diagnostic confidence and efficiency by providing objective, AI-powered analysis of heart and lung sounds, reducing the guesswork in auscultation. Its telehealth capabilities enable seamless remote consultations and monitoring, improving access to specialist care and facilitating flexible staffing. The platform's hardware neutrality allows integration with existing digital stethoscopes, minimizing the need for new equipment. For educational purposes, the Littmann® Learning App offers a valuable tool for training and improving auscultation skills. The ability to record and compare auscultation sounds over time is particularly useful for monitoring patient conditions and clinical documentation.

eMurmur is designed as an open medical AI platform, allowing its Heart and Lung AI to be integrated into digital stethoscopes, connected health devices, and telehealth platforms via secure APIs. They partner with leading hardware and telehealth providers, and their technology is integrated into products like Withings BeamO for in-home heart sound analysis. The platform can also run parallel to existing telemedicine software within a browser for live virtual auscultation. Recordings can be integrated into electronic health records (EHRs).

Products by eMurmur

2 products in the directory

eMurmur Heart AI
eMurmur
Cardiology AI
eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings.
eMurmur ID
eMurmur
Cardiology AI
AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers.

What the Web Says

eMurmur offers a software platform with AI-assisted heart sound analysis for detecting and classifying heart murmurs, cleared as a Class II medical device by the U.S. FDA. The platform supports various digital stethoscopes and provides features for recording, visualizing, storing, and sharing auscultation data for heart, lung, and bowel health. While there is positive feedback on its clinical utility and accuracy in studies, general user reviews on platforms like G2, Glassdoor, Capterra, and Reddit are scarce or refer to different products named "Murmur."

Overall: Positive

Strengths

  • AI-assisted heart sound analysis for murmur detection with high sensitivity and specificity.
  • FDA 510(k) clearance as a Class II medical device.
  • Wide compatibility with various digital stethoscopes.
  • Web-based platform with secure storage, browser and cloud integration, and 24/7 access to data.
  • Supports tele-auscultation for remote consultation and live streaming.
  • HIPAA & GDPR compliant with end-to-end encryption.

Limitations

  • Limited public user reviews available on major platforms like G2, Glassdoor, Capterra, and Reddit for the specific eMurmur product.
  • Some search results for "Murmur" on review sites refer to unrelated advertising or EMR software.

Based on reviews from: G2, Google Search, Apple App Store, Certified Health Apps

Last updated: 2026-10-22

Videos

News, demos, and interviews about eMurmur.

Loading videos...

Videos load interactively. If none appear, search YouTube for eMurmur →

View all on YouTube

Press & Coverage

MassDevice
FDA clears eMurmur's next-gen AI heart murmur detection software
eMurmur received FDA 510(k) clearance for its next-generation heart murmur detection software, eMurmur Heart AI (2.2), which expands compatibility with various digital stethoscopes and introduces new features for analyzing heart sound components. The software assists healthcare providers in screening, monitoring, and diagnosing abnormalities in pediatric and adult patients.
2026-01
PR Newswire
eMurmur's Open Medical AI Receives FDA Clearance, Enabling Murmur Detection Across Digital Stethoscope Models and Third-Party Software
eMurmur announced its third FDA clearance for its Heart AI suite, which automatically identifies primary heart sounds and detects abnormal heart murmurs, as well as providing hemodynamic insights. This clearance makes eMurmur Heart AI an open platform compatible with various stethoscopes and integratable into third-party systems.
2026-01
Medical Product Outsourcing
FDA Clears AI-Powered Heart Murmur Detection Software
eMurmur has secured FDA 510(k) clearance for its AI-powered algorithms that analyze heart recordings from digital stethoscopes, identifying heart sounds and detecting murmurs. This third FDA authorization for eMurmur allows its Heart AI to be an open platform, compatible with various hardware and software solutions.
2026-03
Cardiovascular Business
FDA clears AI software for heart murmur detection with digital stethoscopes
eMurmur, an Ontario-based AI startup, received FDA clearance for its eMurmur Heart AI, a suite of algorithms that evaluate heart recordings from digital stethoscopes to detect heart murmurs and provide hemodynamic data. The software is accessible through eMurmur's standalone platform or third-party systems, marking the company's third FDA clearance for its AI-enabled evaluations.
2026-01
PR Newswire
Lapsi Health and eMurmur® Unveil AI Analytics Integration for Keikku 2.0
Lapsi Health and eMurmur announced the integration of eMurmur's AI analytics into Lapsi Health's Keikku 2.0 platform. This collaboration aims to enhance the capabilities of digital auscultation with advanced AI for analyzing heart and lung sounds.
2025-11
MedDevice Startups
eMurmur Heart AI (K252284): 510(k) cleared Dec 19, 2025
eMurmur Heart AI received 510(k) clearance from the FDA on December 19, 2025. The applicant for this regulatory clearance was Csd Labs, with Andreas Reinisch as the applicant contact.
2025-12
eMurmur (Publications)
Improving Pediatric Care in Rural Hospitals with Telemedicine
A May 2025 study in northeastern Germany demonstrated how a regional tele-paediatric network, utilizing eMurmur's technology for remote heart and lung sound auscultation, improved access to specialist care for children in rural areas. The study reported faster diagnoses, fewer patient transfers, and high satisfaction among healthcare providers.
2025-05
Tracxn
eMurmur - 2026 Company Profile, Funding & Competitors
eMurmur is a funded company that has raised an undisclosed amount across two funding rounds. The first funding round was a grant (prize money) in July 2015.
2026-07

Frequently Asked Questions

eMurmur offers an open medical AI platform for heart and lung sound analysis. Its core products include AI-powered software for automated heart murmur detection and lung sound analysis, which can be used as standalone software or integrated into digital stethoscopes and telehealth platforms. These tools aim to elevate screening, monitoring, diagnosis, and consultation for heart, lung, and bowel health by providing objective insights from auscultation sounds in seconds.
eMurmur is designed as an open platform, compatible with multiple digital stethoscope models and capable of integrating seamlessly into third-party telehealth platforms. It can run parallel to existing telemedicine software in a browser, enabling live, virtual auscultation, remote recording, and asynchronous sharing of auscultation data for specialist consultations.
eMurmur's heart murmur detection technology has received FDA Class II clearance and CE marking (Class IIa). The platform and its AI solutions are clinically validated and compliant with HIPAA and GDPR standards, ensuring secure storage and handling of patient data through end-to-end encryption on secure servers in the US or EU.
eMurmur's Heart AI has demonstrated high accuracy in detecting pathological murmurs, with studies reporting sensitivity of 93% and specificity of 81%, and overall accuracy of 88% compared to cardiologist interpretation and echocardiography. The AI also identifies S1/S2 heart sounds, heart rate, and can detect lung crackles and wheezes, with ongoing development to identify underlying causes of murmurs.
eMurmur requires a license for use, and pricing is dependent on specific use cases, volume, and organizational requirements. Healthcare organizations can request a free 30-day trial to experience the full platform, after which a tailored purchase option and quote can be obtained by contacting eMurmur's sales team.
eMurmur provides structured training, onboarding, standard operating procedures (SOPs), and on-call technical support. They also offer educational solutions, such as the Littmann Learning App, to help medical trainees and professionals master cardiac and pulmonary auscultation skills with access to real patient sounds and guided learning modules.
eMurmur partners with leading hardware manufacturers like Thinklabs and Withings, and telehealth providers to integrate its AI into various devices and platforms. These collaborations expand the reach of eMurmur's technology, enabling clinically validated heart and lung sound analysis in diverse care settings, including remote monitoring and in-home devices.
Founded in 2014, eMurmur is a privately-held medical technology company specializing in machine learning for medical data analysis. They are headquartered in Ottawa, Canada, with R&D operations in Graz, Austria. The company has a strong focus on evidence-based solutions and continuous innovation in AI-powered auscultation, aiming to provide an open, hardware-agnostic AI layer for various recording devices.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.